Stay updated on Autologous DCs+Tumor Lysate+Nivolumab in Recurrent Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Autologous DCs+Tumor Lysate+Nivolumab in Recurrent Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Autologous DCs+Tumor Lysate+Nivolumab in Recurrent Glioblastoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision label updated from v3.2.0 to v3.3.2. No substantive study information appears to be affected.
    Difference
    0.1%
    Check dated 2025-11-25T14:48:55.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The funding-status notice banner was removed from the page. It previously warned about potential delays and pointed to NIH and government updates for status information.
    Difference
    0.4%
    Check dated 2025-11-18T07:29:45.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    No significant additions or deletions were detected on the page; the study details and eligibility criteria appear unchanged.
    Difference
    0.4%
    Check dated 2025-10-27T21:10:47.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    Major update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.
    Difference
    3%
    Check dated 2025-10-06T08:55:17.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    The page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.
    Difference
    0.1%
    Check dated 2025-09-29T07:30:41.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Page version updated from v3.0.1 to v3.0.2 and the 'Back to Top' link was removed. No substantive content changes were detected.
    Difference
    0.2%
    Check dated 2025-09-14T23:29:52.000Z thumbnail image

Stay in the know with updates to Autologous DCs+Tumor Lysate+Nivolumab in Recurrent Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Autologous DCs+Tumor Lysate+Nivolumab in Recurrent Glioblastoma Clinical Trial page.